• 151,382+ Medical Conferences
  • 284 Specialties
  • 11,136 Organizers
  • 155,450 Speakers
  • 159 Countries
  • 4,743 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Howard I. Scher
Howard I. Scher

Howard I. Scher

Co-Chair, Head | New York, New York    United States of America
Oncology, Internal Medicine
Molecular And Phenotypic Features Of Disseminatin Oncology,...More
Spoken at 5 events

Biography :

Howard I. Scher, MD has helped elucidate key molecular and genetic features of prostate cancer and has translated these insights into the clinical evaluation of novel targeted agents including abiraterone and enzalutamide. His research is focused on the validation of circulating tumor cells and other blood-based biomarker assays to biologically profile individual patient tumors to better select and monitor the effects of therapy. Dr. Scher led the international Prostate Cancer Clinical Trials Working Group effort standardize the design and analysis of phase II trials, and serves as the principal investigator of an NIH-supported Specialized Program of Research Excellence in Prostate Cancer, Prostate Cancer Clinical Trials Consortium and the Department of Defense Transformative Impact Award: Toward the Practice of Precision Medicine – A Biomarker Validation Coordinating Center.

For speaker's contact information - Contact us


Oncology, Internal Medicine

Interested Topics

Molecular and Phenotypic Features of Disseminating Cells, Oncology, Internal Medicine, Androgen Receptor (AR), Metastatic Castration, Prostate Cancer, Biotechnology, Molecular Biology, immunology, Cell Biology, Pharmaceutical Industry, Medical Education, Clinical Research

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.



Conference Session Materials


Send Message